Danielle Ribeiro Campos da Silva

Mrs. Danielle Ribeiro Campos da Silva


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Genes
Verified
Journal Article
Open access
PDF file
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
DMDébora Dummer Meira
Débora Dummer Meira
LMLuiza Poppe Merigueti
Luiza Poppe Merigueti
MCMatheus Correia Casotti
Matheus Correia Casotti
DVDiego Ventorim
Diego Ventorim
ILIuri Drumond Louro
Iuri Drumond Louro
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.

26 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
MCMatheus Correia Casotti
Matheus Correia Casotti
DMDébora Dummer Meira
Débora Dummer Meira
AZAléxia Stefani Siqueira Zetum
Aléxia Stefani Siqueira Zetum
BABruno Cancian De Araujo
Bruno Cancian De Araujo
DSDanielle Ribeiro Campos da Silva
Danielle Ribeiro Campos da Silva
ILIuri Drumond Louro
Iuri Drumond Louro
Precision and organization govern the cell cycle, ensuring normal proliferation. However, some cells may undergo abnormal cell divisions (neosis) or variations of mitotic cycles (endopolyploidy). Consequently, the formation of polyploid giant cancer cells (PGCCs), critical for tumor survival, resistance, and immortalization, can occur. Newly formed cells end up accessing numerous multicellular and unicellular programs that enable metastasis, drug resistance, tumor recurrence, and self-renewal or diverse clone formation. An integrative literature review was carried out, searching articles in several sites, including: PUBMED, NCBI-PMC, and Google Academic, published in English, indexed in referenced databases and without a publication time filter, but prioritizing articles from the last 3 years, to answer the following questions: (i) “What is the current knowledge about polyploidy in tumors?”; (ii) “What are the applications of computational studies for the understanding of cancer polyploidy?”; and (iii) “How do PGCCs contribute to tumorigenesis?”